Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety.

Paola PonzaniCesare BerraAlessandra Di LelioPaola Del SindacoChiara Di LoretoFrancesco ReggianiGiuseppe LucisanoMaria Chiara Rossi

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)

These real-world data documented that initiating IDeg or switching to IDeg from other basal insulins in type 2 diabetes was associated with significant improvement in metabolic control without significant weight gain; a decrease in the risk of hypoglycemia was observed when switching to IDeg from another basal insulin.

Keyphrases

type diabetes
weight gain
glycemic control
body mass index
electronic health record
birth weight
cardiovascular disease
big data
insulin resistance
weight loss
metabolic syndrome
physical activity
adipose tissue
artificial intelligence
gestational age
deep learning